Published in Circulation on November 23, 1999
Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol (2006) 1.72
Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol (2009) 1.68
C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med (2007) 1.64
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study. Arthritis Res Ther (2006) 1.52
Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum (2011) 1.49
Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.20
Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis (2000) 1.15
Adult-onset asthma is associated with increased carotid atherosclerosis among women in the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis (2006) 1.08
Vitamin C and the risk of developing inflammatory polyarthritis: prospective nested case-control study. Ann Rheum Dis (2004) 1.07
Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheum Dis Clin North Am (2010) 1.06
Immune aging and rheumatoid arthritis. Rheum Dis Clin North Am (2010) 1.05
Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis Rheum (2006) 1.02
Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol (2015) 1.02
Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis (2007) 1.00
Genetic markers of cardiovascular disease in rheumatoid arthritis. Mediators Inflamm (2012) 0.99
Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol (2009) 0.98
TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. Clin Rheumatol (2007) 0.97
Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Ann Rheum Dis (2008) 0.96
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther (2009) 0.96
Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol (2014) 0.91
Rheumatoid arthritis, periodontal disease and coronary artery disease. Clin Rheumatol (2007) 0.90
[Rheumatoid arthritis and cardiovascular complications]. Z Rheumatol (2006) 0.88
Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis. Rheumatol Int (2006) 0.88
Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. Mediators Inflamm (2014) 0.88
Echocardiographic evaluation of cardiac diastolic function in patients with rheumatoid arthritis: 5 years of follow-up. Clin Rheumatol (2008) 0.86
Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? Arthritis Res Ther (2005) 0.86
Correlation of mean platelet volume, neutrophil-to-lymphocyte ratio, and disease activity in children with juvenile ıdiopathic arthritis. Int J Clin Exp Med (2015) 0.86
The problem of accelerated atherosclerosis in systemic lupus erythematosus: insights into a complex co-morbidity. Thromb Haemost (2011) 0.85
Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet's disease. Rheumatol Int (2006) 0.84
Carotid intima-media thickness is increased in subjects with ischemic heart disease having a familial incidence. Exp Clin Cardiol (2006) 0.82
Glutathione S-transferase M1, T1, and P1 gene polymorphisms and carotid atherosclerosis in Korean patients with rheumatoid arthritis. Rheumatol Int (2003) 0.79
Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease. Int J Mol Sci (2015) 0.79
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis. World J Orthop (2014) 0.79
Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors. Clin Rheumatol (2015) 0.78
Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints. Am J Pathol (2001) 0.78
Cardiac involvement in juvenile idiopathic arthritis. Rheumatol Int (2016) 0.78
Overview of vasculitis and vasculopathy in rheumatoid arthritis--something to think about. Clin Rheumatol (2013) 0.78
Effect of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor on disease activity in patients with rheumatoid arthritis: a meta-analysis. Medicine (Baltimore) (2015) 0.77
Immunoactivation at the crossroads of human disease. Am J Med (2015) 0.77
Right ventricular diastolic abnormalities in rheumatoid arthritis and its relationship with left ventricular and pulmonary involvement. A tissue Doppler echocardiographic study. Int J Cardiovasc Imaging (2006) 0.77
Preliminary Report of Endovascular Treatment for Critical Limb Ischemia Patients with Connective Tissue Disease: Cases Series and Review of the Literature. Int J Angiol (2015) 0.76
Statin Modulation of Human T-Cell Proliferation, IL-1β and IL-17 Production, and IFN-γ T Cell Expression: Synergy with Conventional Immunosuppressive Agents. Int J Inflam (2013) 0.76
Cardiovascular Complications of Collagen Vascular Disease. Curr Treat Options Cardiovasc Med (2002) 0.75
Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial. Trials (2014) 0.75
Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 0.75
Effects of C-reactive protein on K(+) channel interaction protein 2 in cardiomyocytes. Am J Transl Res (2015) 0.75
Atherosclerosis: Is it time for a new name? Circulation (2001) 0.75
The beneficial effects of Tai Chi exercise on endothelial function and arterial stiffness in elderly women with rheumatoid arthritis. Arthritis Res Ther (2015) 0.75
Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Open Access Rheumatol (2009) 0.75
Expression of adiponectin, chemerin and visfatin in plasma and different tissues during a laying season in turkeys. Reprod Biol Endocrinol (2015) 0.75
Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion. PLoS One (2016) 0.75
[Cardiovascular manifestations in inflammatory rheumatic diseases]. Z Rheumatol (2005) 0.75
Tc-99m sestamibi lower extremity muscle scan, is it a useful screening tool for assessment of preclinical atherosclerosis in rheumatoid arthritis patients? Rheumatol Int (2011) 0.75
Influence of serum folic acid levels on plasma homocysteine concentrations in patients with rheumatoid arthritis. Rheumatol Int (2005) 0.75
Dietary alpha lipoic acid supplementation prevents synovial inflammation and bone destruction in collagen-induced arthritic mice. Rheumatol Int (2010) 0.75
Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation (2000) 4.81
Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med (1996) 3.21
p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest (2001) 3.02
Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem (1997) 2.64
Identification of three major sentrinization sites in PML. J Biol Chem (1998) 2.54
Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol (1996) 2.47
Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem (2000) 2.34
Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem (1998) 2.15
Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway. J Biol Chem (1999) 2.15
Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation (2000) 2.15
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation (2001) 2.03
Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol (1999) 1.95
Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J Biol Chem (1997) 1.86
Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J Biol Chem (1997) 1.80
Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1. Cell (1986) 1.77
Identification of NEDD8-conjugation site in human cullin-2. Biochem Biophys Res Commun (1999) 1.63
Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res (2000) 1.53
TAP, a novel T cell-activating protein involved in the stimulation of MHC-restricted T lymphocytes. J Exp Med (1986) 1.49
Identification of defects in glycosylphosphatidylinositol anchor biosynthesis in the Thy-1 expression mutants. J Biol Chem (1991) 1.41
Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBS Lett (1999) 1.33
Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J Biol Chem (2000) 1.33
Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins. J Biol Chem (2000) 1.30
Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol (1996) 1.29
Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem (2001) 1.29
Characterization of a second member of the sentrin family of ubiquitin-like proteins. J Biol Chem (1998) 1.28
Prognostic role of heart rate variability in patients with a recent acute myocardial infarction. Am J Cardiol (1998) 1.28
Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation (1998) 1.25
A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation in vivo. J Biol Chem (2000) 1.24
Correction of the class H defect in glycosylphosphatidylinositol anchor biosynthesis in Ltk- cells by a human cDNA clone. J Biol Chem (1993) 1.20
Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest (1997) 1.20
C-reactive protein: linking inflammation to cardiovascular complications. Circulation (2001) 1.18
NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J Biol Chem (2001) 1.17
Cleavage of the C-terminus of NEDD8 by UCH-L3. Biochem Biophys Res Commun (1998) 1.16
Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol (1999) 1.15
Stimulation of T cells via the TAP molecule, a member in a family of activating proteins encoded in the Ly-6 locus. J Immunol (1987) 1.14
Identification of a missing link in glycosylphosphatidylinositol anchor biosynthesis in mammalian cells. J Biol Chem (1992) 1.13
Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene (1998) 1.12
Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. Am J Respir Crit Care Med (1999) 1.10
Complexity of ethanolamine phosphate addition in the biosynthesis of glycosylphosphatidylinositol anchors in mammalian cells. J Biol Chem (1992) 1.04
The expression, function, and ontogeny of a novel T cell-activating protein, TAP, in the thymus. J Immunol (1986) 1.03
Activation-induced aggregation and processing of the human Fas antigen. Detection with cytoplasmic domain-specific antibodies. J Biol Chem (1997) 1.03
The von Hippel-Lindau tumor suppressor gene product promotes, but is not essential for, NEDD8 conjugation to cullin-2. J Biol Chem (1999) 1.01
Gene encoding T-cell-activating protein TAP maps to the Ly-6 locus. Proc Natl Acad Sci U S A (1986) 1.01
Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene (1998) 0.99
Biosynthesis of phosphatidylinositol-glycan (PI-G)-anchored membrane proteins in cell-free systems: PI-G is an obligatory cosubstrate for COOH-terminal processing of nascent proteins. Proc Natl Acad Sci U S A (1992) 0.96
Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription. Lipids (1996) 0.93
Retracted Diagnostic accuracy of 320-row computed tomography as compared with invasive coronary angiography in unselected, consecutive patients with suspected coronary artery disease. Int J Cardiovasc Imaging (2012) 0.90
Analysis of thymocyte MHC specificity with thymocyte hybridomas. J Exp Med (1984) 0.90
Inhibition of glycosylphosphatidylinositol anchor formation by mannosamine. J Biol Chem (1992) 0.89
Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X. Am J Cardiol (1999) 0.89
Usefulness of the addition of heart rate variability to Holter monitoring in predicting in-hospital cardiac events in patients with unstable angina pectoris. Am J Cardiol (1997) 0.87
Life and death in the cardiovascular system. Circulation (1997) 0.87
A comparative study on the xenotransplantability of human solid tumors into mice with different genetic immune deficiencies. Int J Cancer (1991) 0.87
Identification of novel isoforms of human RAD52. Biochim Biophys Acta (1999) 0.86
A cyclic hexapeptide is a potent antagonist of alpha 4 integrins. J Immunol (1997) 0.86
Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice. J Immunol (1987) 0.84
A tissue plasminogen activator/P-selectin fusion protein is an effective thrombolytic agent. Circulation (1997) 0.83
GNB1L, a gene deleted in the critical region for DiGeorge syndrome on 22q11, encodes a G-protein beta-subunit-like polypeptide. Biochim Biophys Acta (2000) 0.82
Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case against. Dig Liver Dis (2000) 0.81
Expression of T-cell-activating protein in peripheral lymphocyte subsets. Proc Natl Acad Sci U S A (1986) 0.81
Ischemic-like ST-segment changes during Holter monitoring in patients with angina pectoris and normal coronary arteries but negative exercise testing. Am J Cardiol (1997) 0.80
Helicobacter pylori infection and ischaemic heart disease. Ital J Gastroenterol Hepatol (1998) 0.80
Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor. Am J Physiol Heart Circ Physiol (2000) 0.79
Differential expression of glycosylphosphatidylinositol-anchored proteins in a murine T cell hybridoma mutant producing limiting amounts of the glycolipid core. Implications for paroxysmal nocturnal hemoglobinuria. J Clin Invest (1992) 0.79
Role of different determinants of psychological distress in acute coronary syndromes. J Am Coll Cardiol (1998) 0.78
Ischaemic preconditioning. Lancet (1996) 0.78
Circulating endothelial progenitor cells in postmenopausal women with and without coronary artery disease. Climacteric (2009) 0.77
Selection of thymocyte MHC restriction specificity in vitro. J Mol Cell Immunol (1984) 0.77
Cardiac autonomic function and sensitivity to pain in postmenopausal women with angina and normal coronary arteries. Am J Cardiol (1997) 0.77
No evidence of perinatal transmission of HTLV-II. J Acquir Immune Defic Syndr (1993) 0.76
A new echo-Doppler method to measure interatrial conduction time. Validation and clinical usefulness. Minerva Cardioangiol (2011) 0.76
Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina. Cardiologia (1999) 0.76
Comparison of four enzyme immunoassays for detection of human T-cell lymphotropic virus type 2 antibodies. J Clin Microbiol (1996) 0.76
Comparison of indirect immunofluorescence and membrane fluorescence assays for the differentiation of antibodies to human immunodeficiency virus types 1 and 2. J Clin Microbiol (1992) 0.75
Is the benefit of preinfarction angina on infarct size due to faster coronary recanalization? Circulation (1995) 0.75
Subarachnoid hemorrhage and acute myocardial infarction. N Engl J Med (1996) 0.75
Autoimmunity and the pathogenesis of myocarditis. Circulation (1994) 0.75
Effects of bamiphylline on exercise testing in patients with syndrome X. G Ital Cardiol (1997) 0.75
Primary coronary angioplasty versus thrombolysis. N Engl J Med (1997) 0.75
Expanding concepts in ischaemic heart disease: implications for clinical practice and research. Q J Nucl Med (1996) 0.75
Abnormal T cells from MRL/Mp-lpr/lpr mice do not respond to anti-T-cell-receptor antibody or tumor promoter and calcium ionophore A23187 despite the presence of the T-cell-receptor complex and protein kinase c. Cell Immunol (1988) 0.75
Suppression of autoimmune disease by omega-3 fatty acids. Biochem Soc Trans (1995) 0.75
Defective signal transduction in CD4-CD8- T cells of lpr mice. Cell Immunol (1989) 0.75
Structure and function of the TAP protein and related Ly-6-linked molecules. Year Immunol (1988) 0.75
T cell-activating protein on murine lymphocytes. Fed Proc (1986) 0.75
Defects in signal transduction caused by a T cell receptor beta chain substitution. Eur J Immunol (1990) 0.75
Selection of T cell receptor expression mutants through the functionally linked Ly-6A. Cell Immunol (1990) 0.75
[Improvement of the prognosis in ischemic cardiopathy: cause and effect on the prognostic value of tests]. Cardiologia (1995) 0.75
Differential effects of endothelin receptor activation on cyclic flow variations in rat mesenteric arteries. Circulation (1997) 0.75
The GPI tail: correction. N Engl J Med (1994) 0.75
Is there an antigenic mimicry between arteriosclerotic lesions and H. pylori antigens? Clin Biochem (2000) 0.75